Results
Differentially Expressed miRNAs List
miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
---|---|---|---|---|---|---|---|---|
hsa-miR-20b | GSE6188 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | 0.53 | UP | EXP00031 |
hsa-miR-20b | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.44 | UP | EXP00042 |
hsa-miR-20b | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.46 | UP | EXP00044 |
hsa-miR-20b | GSE10694 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.44 | UP | EXP00052 |
hsa-miR-20b | GSE17498 | lymphoma | lymphoma | N/A | cancer vs normal | -1.64 | DOWN | EXP00086 |
hsa-miR-20b | GSE17498 | lymphoma | lymphoma | N/A | high grade vs low grade | 1.52 | UP | EXP00088 |
hsa-miR-20b | GSE18509 | melanoma | melanoma | N/A | metastasis | 2.19 | UP | EXP00089 |
hsa-miR-20b | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | -0.82 | DOWN | EXP00090 |
hsa-miR-20b | GSE19387 | melanoma | melanoma | N/A | metastasis | -0.07 | DOWN | EXP00099 |
hsa-miR-20b | GSE21036 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.54 | UP | EXP00101 |
hsa-miR-20b | GSE20099 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -0.71 | DOWN | EXP00079 |
hsa-miR-20b | GSE20099 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | -0.55 | DOWN | EXP00080 |
hsa-miR-20b | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | 0.48 | UP | EXP00070 |
hsa-miR-20b | GSE11016 | kidney cancer | kidney cancer | N/A | cancer vs normal | 1.49 | UP | EXP00054 |
hsa-miR-20b | GSE11016 | kidney cancer | kidney cancer | N/A | cancer vs normal | 0.86 | UP | EXP00055 |